Clinical Trials Logo

Clinical Trial Summary

This study is designed to evaluate the safety, tolerability and efficacy of long-term treatment with PF-06741086 in subjects with severe hemophilia who participated in the 3-month Phase 1b/2 B7841002 study. Additionally, de novo subjects will be recruited into this study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03363321
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 2
Start date May 30, 2018
Completion date August 5, 2020

See also
  Status Clinical Trial Phase
Completed NCT02974855 - PF-06741086 Multiple Dose Study in Severe Hemophilia Phase 2